Regulatory T cells suppress osteoclast formation: A new link between the immune system and bone

Regulatory T cells suppress osteoclast formation: A new link between the immune system and bone

Opis bibliograficzny
Główni autorzy:	Zaiss, M, Axmann, R, Zwerina, J, Polzer, K, Gueckel, E, Skapenko, A, Schulze-Koops, H, Horwood, N, Cope, A, Schett, G
Format:	Conference item
Wydane:	2008

Podobne zapisy

Treg cells suppress osteoclast formation: a new link between the immune system and bone.
od: Zaiss, M, i wsp.
Wydane: (2007)

Analysis of the transcriptional program of developing induced regulatory T cells.
od: Iryna Prots, i wsp.
Wydane: (2011-01-01)

An osteogenic helioxanthin derivative suppresses the formation of bone-resorbing osteoclasts
od: Hitoshi Amano, i wsp.
Wydane: (2019-12-01)

Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines
od: Hendrik Schulze-Koops, i wsp.
Wydane: (2021-04-01)

The Tec kinases: Bmx and Btk play distinct regulatory roles in osteoclast differentiation
od: Danks, L, i wsp.
Wydane: (2005)

Spontaneous abortion as differential diagnosis of intermittent glomerular proteinuria in inactive systemic lupus erythematosus
od: Fabian T. H. Ullrich, i wsp.
Wydane: (2023-07-01)

NK cells support osteoclast formation in vitro
od: Danks, L, i wsp.
Wydane: (2005)

How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
od: Ulrike Steffen, i wsp.
Wydane: (2019-07-01)

Serpinb1a suppresses osteoclast formation
od: Masayoshi Ishida, i wsp.
Wydane: (2021-07-01)

Interleukin-12 inhibits osteoclast formation via T cells.
od: Horwood, N, i wsp.
Wydane: (2000)

NK cells support osteoclast formation in vitro
od: Owen, S, i wsp.
Wydane: (2004)

Activated T lymphocytes support osteoclast formation in vitro.
od: Horwood, N, i wsp.
Wydane: (1999)

The Beneficial Effect of Praeruptorin C on Osteoporotic Bone in Ovariectomized Mice via Suppression of Osteoclast Formation and Bone Resorption
od: Xuqiang Liu, i wsp.
Wydane: (2017-09-01)

A rare side effect of methotrexate therapy: drug-induced osteopathy with multiple fractures of the lower limb
od: Hendrik Schulze-Koops, i wsp.
Wydane: (2023-02-01)

Beyond resorption: osteoclasts as drivers of bone formation
od: Qianfeng Xiang, i wsp.
Wydane: (2024-10-01)

Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase
od: Darja Andreev, i wsp.
Wydane: (2024-02-01)

What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?
od: Teun J. de Vries, i wsp.
Wydane: (2019-03-01)

Elevated cytokine production restores bone resorption by human Btk-deficient osteoclasts.
od: Danks, L, i wsp.
Wydane: (2011)

In vitro and in vivo studies on exogenous polyamines and α-difluoromethylornithine to enhance bone formation and suppress osteoclast differentiation
od: Chien-Ching Lee, i wsp.
Wydane: (2024-06-01)

Polymorphonuclear Neutrophils in Osteomyelitis: Link to Osteoclast Generation and Bone Resorption
od: M.M. Gaida, i wsp.
Wydane: (2012-09-01)

Cellular mechanisms of osteoclast formation and bone resorption in rheumatoid arthritis
od: Danks, L, i wsp.
Wydane: (2001)

Interleukin-12 alone, and in synergy with interleukin-18, inhibits osteoclast formation in vitro
od: Horwood, N, i wsp.
Wydane: (2001)

IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro.
od: Horwood, N, i wsp.
Wydane: (2001)

Breast cancer cells interact with osteoblasts to support osteoclast formation.
od: Thomas, R, i wsp.
Wydane: (1999)

3,3′-Diindolylmethane increases bone mass by suppressing osteoclastic bone resorption in mice
od: Tai-yong Yu, i wsp.
Wydane: (2015-01-01)

Expression of Bruton's tyrosine kinase in osteoclasts
od: Danks, L, i wsp.
Wydane: (2005)

Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow.
od: Mansour, A, i wsp.
Wydane: (2012)

Osteostaticytes: A novel osteoclast subset couples bone resorption and bone formation
od: Zhiyuan Wei, i wsp.
Wydane: (2024-07-01)

Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling
od: Qinyu Ma, i wsp.
Wydane: (2021-01-01)

The role of light in osteoclast formation and pathological bone resorption in rheumatoid arthritis
od: Athanasou, NA, i wsp.
Wydane: (2017)

Procoxacin bidirectionally inhibits osteoblastic and osteoclastic activity in bone and suppresses bone metastasis of prostate cancer
od: Depei Kong, i wsp.
Wydane: (2023-02-01)

Ceritinib (LDK378) prevents bone loss via suppressing Akt and NF-κB-induced osteoclast formation
od: Wenxin He, i wsp.
Wydane: (2022-11-01)

Isoliensinine Suppresses Osteoclast Formation Through NF-κB Signaling Pathways and Relieves Ovariectomy-Induced Bone Loss
od: Huijiang Liu, i wsp.
Wydane: (2022-07-01)

Transcriptional reprogramming during human osteoclast differentiation identifies regulators of osteoclast activity
od: Morten S. Hansen, i wsp.
Wydane: (2024-01-01)

Suppressive effects of (-)-tubaic acid on RANKL-induced osteoclast differentiation and bone resorption
od: Soomin Lim, i wsp.
Wydane: (2023-12-01)

Bruton's tyrosine kinase (Btk) inhibitor tirabrutinib suppresses osteoclastic bone resorption
od: Yuko Ariza, i wsp.
Wydane: (2019-06-01)

Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss.
od: Yoshiki Nakashima, i wsp.
Wydane: (2013-01-01)

Osteoclast Activation and Inflammatory Bone Diseases: Focusing on Receptors in Osteoclasts
od: Zhao W, i wsp.
Wydane: (2025-03-01)

Involvement of RANKL-dependent/independent mechanisms in osteoclast formation in aseptic loosening
od: Sabokbar, A, i wsp.
Wydane: (2001)

Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
od: Sabokbar, A, i wsp.
Wydane: (2003)